These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2276342

  • 1. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW, Anderson DR, Pastelak AM, Vanderpool B.
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [Abstract] [Full Text] [Related]

  • 2. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure.
    Anderson DR, Harris LW, Lennox WJ, Solana RP.
    Drug Chem Toxicol; 1991; 14(1-2):1-19. PubMed ID: 1889370
    [Abstract] [Full Text] [Related]

  • 3. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
    Harris LW, Talbot BG, Lennox WJ, Anderson DR, Solana RP.
    Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP, Gennings C, Carter WH, Anderson D, Lennox WJ, Carchman RA, Harris LW.
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [Abstract] [Full Text] [Related]

  • 7. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication.
    Harris LW, Anderson DR, Lennox WJ, Solana RP.
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):267-71. PubMed ID: 2922758
    [Abstract] [Full Text] [Related]

  • 8. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
    Lennox WJ, Harris LW, Talbot BG, Anderson DR.
    Life Sci; 1985 Sep 02; 37(9):793-8. PubMed ID: 4033355
    [Abstract] [Full Text] [Related]

  • 9. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
    von Bredow J, Corcoran K, Maitland G, Kaminskis A, Adams N, Wade J.
    Fundam Appl Toxicol; 1991 Nov 02; 17(4):782-9. PubMed ID: 1778364
    [Abstract] [Full Text] [Related]

  • 10. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
    Philippens IH, Vanwersch RA, Groen B, Olivier B, Bruijnzeel PL, Melchers BP.
    Toxicol Sci; 2000 Jan 02; 53(1):84-91. PubMed ID: 10653525
    [Abstract] [Full Text] [Related]

  • 11. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
    Ray R, Clark OE, Ford KW, Knight KR, Harris LW, Broomfield CA.
    Fundam Appl Toxicol; 1991 Feb 02; 16(2):267-74. PubMed ID: 2055358
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs.
    Meshulam Y, Davidovici R, Wengier A, Levy A.
    J Appl Toxicol; 1995 Feb 02; 15(4):263-6. PubMed ID: 7594194
    [Abstract] [Full Text] [Related]

  • 13. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR.
    J Pharm Pharmacol; 1994 Dec 02; 46(12):1023-8. PubMed ID: 7714714
    [Abstract] [Full Text] [Related]

  • 14. Successful pretreatment/therapy of soman, sarin and VX intoxication.
    Lennox WJ, Harris LW, Anderson DR, Solana RP, Murrow ML, Wade JV.
    Drug Chem Toxicol; 1992 Dec 02; 15(4):271-83. PubMed ID: 1459040
    [Abstract] [Full Text] [Related]

  • 15. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation.
    Kawabuchi M, Boyne AF, Deshpande SS, Cintra WM, Brossi A, Albuquerque EX.
    Synapse; 1988 Dec 02; 2(2):139-47. PubMed ID: 3420535
    [Abstract] [Full Text] [Related]

  • 16. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM, Brecht KM, Lenz DE, O'Neill BL.
    J Pharmacol Exp Ther; 1988 Sep 02; 246(3):986-91. PubMed ID: 3418520
    [Abstract] [Full Text] [Related]

  • 17. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs.
    Philippens IH, Melchers BP, Olivier B, Bruijnzeel PL.
    Pharmacol Biochem Behav; 2000 Jan 01; 65(1):175-82. PubMed ID: 10638651
    [Abstract] [Full Text] [Related]

  • 18. Trihexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea pigs.
    Lim DK, Hoskins B, Ho IK.
    Fundam Appl Toxicol; 1991 Apr 01; 16(3):482-9. PubMed ID: 1855620
    [Abstract] [Full Text] [Related]

  • 19. Comparing the response surfaces of two cholinolytics when used in combination with physostigmine as a pretreatment against organophosphate challenge.
    Solana RP, Gennings C, Anderson D, Carter WH, Carchman RA, Harris LW.
    Drug Chem Toxicol; 1989 Apr 01; 12(3-4):197-219. PubMed ID: 2632243
    [Abstract] [Full Text] [Related]

  • 20. 3-Carbamyl-N-allylquinuclidinium bromide. Effects on cholinergic activity and protection against soman.
    Sterling GH, Doukas PH, Jackson C, Caccese R, O'Neill KJ, O'Neill JJ.
    Biochem Pharmacol; 1993 Jan 26; 45(2):465-72. PubMed ID: 8435096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.